International Stem Cell Corp. (ISCO) Makes Significant Advancement in Stem Cell Technology
International Stem Cell, a biotech company focused on the development and commercialization of stem cell-based research and cosmetic products, recently reported a significant advancement in human induced pluripotent stem cells (iPS) derivation with novel protein-based reprogramming method. iPS cells are made by genetically reprogramming mature cells, which are usually taken from the skin, and can be used to create new cells of a different type. Original reprogramming methods utilize viruses to modify the cells genes and risk the inclusion of genetic material from the virus into the cells. These viral methods have proven extremely inefficient and can only produce limited…